Optain

New York, United States · Founded 2023

Headquarters
New York, New York
Employees
11–50
Founded
2023
Business Model
B2B
Last Round
Series ASep 2025
Rounds
2

About

Optain is an AI-enabled retinal screening company that combines a portable camera with advanced algorithms to detect over 140 eye and systemic conditions non-invasively at the point of care. The platform screens for diabetic retinopathy, glaucoma, macular degeneration, and cardiovascular risk in under 60 seconds with over 90% accuracy. Founded in 2023 and backed by Aegis Ventures and Northwell Health, Optain targets clinical and primary care settings globally.

Summary

Optain is an Artificial Intelligence company based in New York, United States, founded in 2023. Its most recent funding was a Series A round in Sep 2025. Investors include Insight Partners, Aegis Ventures and Northwell Holdings.

Tech & App Stack

4 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies